Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W David Strain

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Diabetologia|October 7, 2017
Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemiaSuzy V Hope, Bridget A Knight, Beverley M Shields, et al.
Stroke|May 18, 2022
Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6W David Strain, Ofir Frenkel, Martin A James, et al.
Journal of the American Geriatrics Society|January 1, 2017
Outcomes of Treated Hypertension at Age 80 and Older: Cohort Analysis of 79,376 IndividualsJoão Delgado, Jane A H Masoli, Kirsty Bowman, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 29, 2022
Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think DifferentlyMarc Evans, Angharad R Morgan, Stephen C Bain, et al.
Journal of Hypertension|December 8, 2021
Carotid-femoral pulse wave velocity acquisition methods and their associations with cardiovascular risk factors and subclinical biomarkers of vascular healthKunihiko Aizawa, Phillip E Gates, David M Mawson, et al.
Diabetologia|March 19, 2020
Weight change and sulfonylurea therapy are related to 3 year change in microvascular function in people with type 2 diabetesFrancesco Casanova, Kim M Gooding, Angela C Shore, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 19, 2022
Meeting the Challenge of Virtual Diabetes Care: A Consensus Viewpoint on the Positioning and Value of Oral Semaglutide in Routine Clinical PracticeMarc Evans, Angharad R Morgan, Stephen C Bain, et al.
Infectious Diseases and Therapy|April 25, 2024
Modelling COVID-19 Vaccination in the UK: Impact of the Autumn 2022 and Spring 2023 Booster CampaignsDiana Mendes, Sheeja Machira Krishnan, Esmé O'Brien, et al.
Diabetes, Obesity & Metabolism|October 8, 2025
Addressing the risk of ocular complications of GLP-1RAs; a multi-disciplinary expert consensusPatrice Carter, Rafael Simó, Monica Lövestam-Adrian, et al.
Advances in Therapy|November 5, 2021
A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future PerspectivesMarc Evans, Ruth D Lewis, Angharad R Morgan, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Diabetologia|October 7, 2017
Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemiaSuzy V Hope, Bridget A Knight, Beverley M Shields, et al.
Stroke|May 18, 2022
Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6W David Strain, Ofir Frenkel, Martin A James, et al.
Journal of the American Geriatrics Society|January 1, 2017
Outcomes of Treated Hypertension at Age 80 and Older: Cohort Analysis of 79,376 IndividualsJoão Delgado, Jane A H Masoli, Kirsty Bowman, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 29, 2022
Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think DifferentlyMarc Evans, Angharad R Morgan, Stephen C Bain, et al.
Journal of Hypertension|December 8, 2021
Carotid-femoral pulse wave velocity acquisition methods and their associations with cardiovascular risk factors and subclinical biomarkers of vascular healthKunihiko Aizawa, Phillip E Gates, David M Mawson, et al.
Diabetologia|March 19, 2020
Weight change and sulfonylurea therapy are related to 3 year change in microvascular function in people with type 2 diabetesFrancesco Casanova, Kim M Gooding, Angela C Shore, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 19, 2022
Meeting the Challenge of Virtual Diabetes Care: A Consensus Viewpoint on the Positioning and Value of Oral Semaglutide in Routine Clinical PracticeMarc Evans, Angharad R Morgan, Stephen C Bain, et al.
Infectious Diseases and Therapy|April 25, 2024
Modelling COVID-19 Vaccination in the UK: Impact of the Autumn 2022 and Spring 2023 Booster CampaignsDiana Mendes, Sheeja Machira Krishnan, Esmé O'Brien, et al.
Diabetes, Obesity & Metabolism|October 8, 2025
Addressing the risk of ocular complications of GLP-1RAs; a multi-disciplinary expert consensusPatrice Carter, Rafael Simó, Monica Lövestam-Adrian, et al.
Advances in Therapy|November 5, 2021
A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future PerspectivesMarc Evans, Ruth D Lewis, Angharad R Morgan, et al.
Pageof 7